Real-world economic impact of onabotulinumtoxina in patients with chronic migraine

被引：0
|
作者：
Rothrock, J. F. [1 ]
Bloudek, L. M. [2 ]
Houle, T. T. [3 ]
Andress-Rothrock, D. [4 ]
Hanlon, C. [1 ]
Varon, S. F. [2 ]
机构：
[1] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[2] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
[3] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[4] Univ Alabama Birmingham, Headache Treatment & Res Program, Birmingham, AL USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2013年 / 14卷
关键词：
Migraine; Chronic Migraine; Episodic Migraine; onabotulinumtoxinA; Urgent Care Center;
D O I：
10.1186/1129-2377-14-S1-P216
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Chronic migraine treatment: from OnabotulinumtoxinA onwards
    Negro, Andrea
    Curto, Martina
    Lionetto, Luana
    Giamberardino, Maria Adele
    Martelletti, Paolo
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1217 - 1227
  • [32] Comparative effectiveness and tolerability of calcitonin gene-related peptide (CGRP) monoclonal antibodies and onabotulinumtoxinA in chronic migraine: A multicenter, real-world study in Taiwan
    Wang, Yen-Feng
    Yang, Fu-Chi
    Chen, Lu-An
    Chang, Ting-Yu
    Su, Hui-Chen
    Yang, Chun-Pai
    Tu, Yi-Hsien
    Tzeng, Yi-Shiang
    Chen, Shih-Pin
    Fuh, Jong-Ling
    Lai, Kuan-Lin
    Ling, Yu-Hsiang
    Chen, Wei-Ta
    Wang, Shuu-Jiun
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (09)
  • [33] Real Life Data on OnabotulinumtoxinA for Treatment of Chronic Migraine in Pediatric Age
    Papetti, Laura
    Frattale, Ilaria
    Ursitti, Fabiana
    Sforza, Giorgia
    Monte, Gabriele
    Ferilli, Michela Ada Noris
    Tarantino, Samuela
    Proietti Checchi, Martina
    Valeriani, Massimiliano
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [34] Real-world insights on the management of migraine patients: an Italian nationwide study
    Agostoni, Elio
    Barbanti, Piero
    Frediani, Fabio
    Trifiro, Gianluca
    Burgio, Luigi
    di Nola, Lisa
    Pegoraro, Valeria
    Pulimeno, Stefania
    Cepparulo, Mario
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (09) : 1545 - 1554
  • [35] A real-world prospective observational study of eptinezumab in Asian patients with migraine
    Zhao, Yi Jing
    Ong, Jonathan Jia Yuan
    Sonu, Sumit Kumar
    Dang, Jiaojiao
    Ng, Chai Ching
    Herr, Keira Joann
    Bose, Rohini
    Jion, Yasmin Idu
    HEADACHE, 2024, 64 (07): : 810 - 824
  • [36] A real-world, observational study of erenumab for migraine prevention in Canadian patients
    Becker, Werner J.
    Spacey, Sian
    Leroux, Elizabeth
    Giammarco, Rose
    Gladstone, Jonathan
    Christie, Suzanne
    Akaberi, Arash
    Power, G. Sarah
    Minhas, Jagdeep K.
    Mancini, Johanna
    Rochdi, Driss
    Filiz, Ayca
    Bastien, Natacha
    HEADACHE, 2022, 62 (04): : 522 - 529
  • [37] Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine
    Robblee, Jennifer
    Devick, Katrina L.
    Mendez, Natasha
    Potter, Jamie
    Slonaker, Jennifer
    Starling, Amaal J.
    HEADACHE, 2020, 60 (09): : 2014 - 2025
  • [38] A prospective real-world analysis of erenumab in refractory chronic migraine
    Giorgio Lambru
    Bethany Hill
    Madeleine Murphy
    Ivona Tylova
    Anna P. Andreou
    The Journal of Headache and Pain, 2020, 21
  • [39] Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study
    Aubrey Manack Adams
    Susan Hutchinson
    Ella Engstrom
    Nicolai D. Ayasse
    Daniel Serrano
    Linda Davis
    Katherine Sommer
    Janette Contreras-De Lama
    Richard B. Lipton
    The Journal of Headache and Pain, 24
  • [40] A prospective real-world analysis of erenumab in refractory chronic migraine
    Lambru, Giorgio
    Hill, Bethany
    Murphy, Madeleine
    Tylova, Ivona
    Andreou, Anna P.
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01)
12345